In addition, immunocytochemistry reveled that CDDO-Me markedly upregulated ATF4 and CHOP in nuclei (Figure 2F), indicating that CDDO-Me is an effective ER stress inducer in breast cancer cells. The gene discussed is ATF4; the disease is breast carcinoma.